Ti trovi qui: Home » People » PhD Students » XXXV cycle

XXXV cycle

Surname and NameDepartmentPhoneE-mailResearch Topics
Calderoni LucaLife Sciences 251111@studenti.unimore.itComputational analysis and modeling of transcriptional data at the single cell level
Carretta ChiaraLife Sciences - CMR chiara.carretta@unimore.itStudy of clonal architecture of stem cell compartment from patients with myelofibrosis
Cattaneo CamillaLife Sciences - CMR camilla.cattaneo@unimore.itAllele-specific gene editing for dominant form of EBS (Epidermolysis Bullosa Simplex)
Consiglio FedericaLife Sciences - CMR federica.consiglio@unimore.itSIN gamma retroviral gene therapy approach for treatment of recessive dystrophic epidermolysis bullosa
Galaverni GiuliaLife Sciences - CMR giulia.galaverni@unimore.itAirway reconstruction using epithelial and chondrocyte respiratory cells on a natural scaffold
Gatti MartinaBiomedical, Metabolical and Neural Sciences 187755@studenti.unimore.itRole of exosomes derived from amniotic fluid stem cells in counteracting age-related disorders
Grandi FrancescoLife Sciences francesco.grandi1993@unimore.itComputational models for the analysis of transcriptional determinants in cancer cell populations
Maffezzoni Maria Benedetta RizzardaLife Sciences - CMR mariabenedettarizzarda.maffezzoni@unimore.itResearch on membrane biofuctionalization for tissue regeneration in odontostomatologic field
Manco Urbina Pamela AllisonLife Sciences pamelaallison.mancourbina@unimore.itDetection of biomarkers of aging with organic electronics
Merra AlessiaLife Sciences - CMR alessia.merra@unimore.itHuman corneal endothelial cell expansion on a biological scaffold
Nesteruk IvannaLife Sciences - CMR ivanna.nesteruk@unimore.itSIN gamma retroviral gene therapy approach for treatment of junctional epidermolysis bullosa col17 dependent
Polito Maria PiaLife Sciences - CMR mariapia.polito@unimore.itMolecular characterization of epidermal stem cells for cell and gene therapy applications
Sartini StefanoLife Sciences - CMR 268146@studenti.unimore.itIdentification of novel profibrotic molecules as new therapeutic targets in myelofibrosis